Financials
- Market Capitalization 768.61 M
- Employee 159
- Founded 2015
- CEO N/A
- Website www.ars-pharma.com
- Headquarter Delaware, United States
- FIGI BBG00FZQGXG3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2609 | CTMX CytomX Therapeutics, Inc. - Common Stock | 3.70 USD | -1.60% | -3.90% | +21.31% | +56.12% | 805.50 M USD | ||
| 2632 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 13.18 USD | -1.27% | -5.79% | +2.89% | +23.87% | 779.14 M USD | ||
| 2642 | RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 41.30 USD | -2.94% | +1.57% | +24.25% | +37.07% | 764.14 M USD | ||
| 2650 | CLYM Climb Bio, Inc. - Common Stock | 13.21 USD | -5.64% | +0.30% | +13.29% | +141.50% | 756.41 M USD |
Frequently asked questions about ARS Pharmaceuticals, Inc. - Common Stock
What is the ARS Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of ARS Pharmaceuticals, Inc. - Common Stock (SPRY) is 7.74. Over the past 24 hours, the stock has changed by -2.52%. Follow the SPRY chart for real-time price dynamics.
What is the stock ticker of ARS Pharmaceuticals, Inc. - Common Stock?
ARS Pharmaceuticals, Inc. - Common Stock trades under the ticker SPRY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ARS Pharmaceuticals, Inc. - Common Stock stock going up?
SPRY has changed by -8.40% over the last week, -21.42% over the last month, and -15.96% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was ARS Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
ARS Pharmaceuticals, Inc. - Common Stock reported net income of -60.62 M for the last quarter. The previous quarter showed -41.32 M, which means net income changed by -46.69%.
How many employees does ARS Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, ARS Pharmaceuticals, Inc. - Common Stock has 159 employees. Workforce size can provide additional context about the company's scale and operations.
What is ARS Pharmaceuticals, Inc. - Common Stock EBITDA?
ARS Pharmaceuticals, Inc. - Common Stock EBITDA is -60.84 M, and its EBITDA margin is -268.22%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ARS Pharmaceuticals, Inc. - Common Stock stock?
You can buy ARS Pharmaceuticals, Inc. - Common Stock (SPRY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ARS Pharmaceuticals, Inc. - Common Stock stock?
Investing in ARS Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SPRY chart and related analysis on metatrader.com as part of your research.